跳转到主要内容
搜索

RADNOR, Pa., 2026 年 7 月 15 日 (GLOBE NEWSWIRE) — Certara, Inc. (纳斯达克股票代码:CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2026 before market open on Tuesday, August 4th, 2026. Company management will host a conference call to discuss financial results at 8:30AM ET.

Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance.

A live and archived webcast of the event will be available on the “Investors” section of the Certara website at https://ir.certara.com/.

关于Certara

Certara transforms drug discovery and development for good, helping scientists and clinical teams generate regulatory-grade evidence faster. Its solutions combine biosimulation, clinical intelligence, and regulatory science, and are embedded in the workflows of drug developers worldwide. Certara clients include more than 2,600 biopharmaceutical companies, academic institutions, and global regulatory agencies. 了解更多信息,请访问 www.certara.com.cn。

Investor Relations Contact:

Erik Abdow
Gilmartin Group
[email protected]

媒体联系人:

Alyssa Horowitz
[email protected]

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software